What NXT-USA does

NXT-USA is a privately held B2B nutraceutical ingredient supplier headquartered in Edison, New Jersey, founded by the team that previously co-founded NattoPharma ASA and introduced vitamin K2 Mk-7 to global markets. The company supplies proprietary, clinically validated botanical ingredients to nutritional supplement manufacturers, finished product brands, and regional distributors. Its portfolio consists of four branded ingredients: TamaFlex (joint health via Tamarind seed and Turmeric root with a patented Triple OX Pathway mechanism), Xeya Modern Shatavari (women's hormonal health, standardized to 15% shatavarins), Digexin (digestive health via a gut-brain axis approach using Okra and Ashwagandha), and BluNADBooster (plant-based NAD+ longevity). Each ingredient is backed by double-blind, placebo-controlled human clinical trials published in peer-reviewed journals, with TamaFlex currently registered and Digexin and BluNADBooster patent-pending.

NXT-USA operates an asset-light model: it owns formulation IP, trademarked brands, and clinical evidence, while manufacturing is outsourced to partners in the United States, Scandinavia, Europe, and India, with sourcing compliant with India's Biological Diversity Act. Revenue is generated through B2B ingredient sales (quote-based, not publicly disclosed) and licensing arrangements with branded customers that include Tylenol (Kenvue), Schiff (Reckitt), GNC, Solgar, MegaFood, Life Extension, Qualia, Gundry MD, and Instaflex. Geographic distribution is supported by channel partners including Shanghai Nutra (China/Asia, 2022) and Infinity Pharma Brazil (Brazil, 2024). The company holds regulatory certifications including Non-GMO Project Verification, Korean MFDS functional food approval for TamaFlex, and cGMP manufacturing compliance.

The company is led by Managing Director Eric Anderson, with Todd Runestad joining as Chief Storytelling Officer in March 2025. Headcount is reported at 1-10 employees and no institutional funding rounds are disclosed, indicating founder-led, bootstrapped operations. Recent strategic emphasis has been on portfolio diversification (two new ingredient launches in 2025), regulatory expansion in Asian markets, and brand storytelling investment, suggesting a transition from a single-ingredient (TamaFlex) supplier to a multi-ingredient, multi-region specialty ingredient platform.

Name

NXT-USA

Legal name

NXT-USA

Website

https://nxt-usa.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

NXT-USA is a privately held B2B nutraceutical ingredient supplier selling four clinically validated proprietary botanical ingredients (TamaFlex, Digexin, Xeya, BluNADBooster) to supplement manufacturers and brands in joint, digestive, women's health, and longevity categories globally.

Ownership category

akta.pro rank

Product category

Nutraceutical Ingredients

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Herbal & Botanical Supplements (CRADAGAD)

akta.pro secondary industries

Healthy Aging & Cognitive Support Supplements (CRADAGAM), Women’s Health Supplements (Prenatal, Menopause, Hormonal) (CRADAGAK)

Keywords

• Nutraceutical ingredient supplier
• Proprietary botanical extracts
• Joint health ingredients
• Digestive health ingredients
• Women's hormonal health ingredients

Headquarters

HQ city

Edison

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. B2B Ingredient Sales: NXT-USA supplies proprietary branded ingredients to nutritional supplement manufacturers and finished product brands. Revenue is generated through ingredient sales, licensing, and partnerships with brands incorporating their clinically validated botanical extracts into their products.
2. B2B Sales Model: Direct B2B sales to qualified industry professionals, manufacturers, and resellers in the United States and globally through distribution partners.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

NXT-USA supplies four proprietary, clinically validated botanical branded ingredients — TamaFlex (joint health), Xeya Modern Shatavari (women's hormonal health), Digexin (digestive health and gut-brain axis), and BluNADBooster (NAD+ longevity) — to nutritional supplement manufacturers and finished product brands globally. Revenue is generated by selling these patented or patent-pending ingredient formulations, backed by human clinical studies, under licensing and direct supply agreements.

Product overview

NXT-USA is a B2B nutraceutical ingredient company providing clinically validated health ingredients to manufacturers. The product portfolio consists of four branded ingredients: TamaFlex (joint health using Tamarind and Turmeric via Triple OX Pathway mechanism), Xeya Modern Shatavari (women's hormonal health for PCOS, perimenopause and menopause support), Digexin (digestive/gut health via gut-brain axis using Okra and Ashwagandha), and BluNADBooster (cellular longevity via NAD+ biosynthesis activation and CD38 inhibition). All products are backed by human clinical trials published in peer-reviewed journals, with emphasis on double-blind, placebo-controlled studies.

Differentiator

Problem solved

Functional benefit

Brands

• TamaFlex: Patented plant-based joint health ingredient combining Tamarind Seed and Turmeric Root Extracts, clinically proven to provide fast-acting and long-lasting joint relief.
• Xeya Modern Shatavari
• Digexin
• BluNADBooster

Products and services

• TamaFlex Patented plant-based joint health ingredient combining Tamarind Seed and Turmeric Root extracts, clinically proven to provide fast-acting (5-day) and long-lasting joint relief through the Triple OX Pathway (COX, LOX, AntiOX). Sold to nutritional supplement manufacturers and brands for use in finished consumer joint-health products.
• Xeya Modern Shatavari Trademarked Ayurvedic adaptogen for women's hormonal health, standardized to 15% shatavarins and clinically validated for hormonal balance across PCOS, perimenopause, and menopause. Effective at a low 50–100 mg/day dose and available in water-dispersible format. Sold B2B to supplement brands formulating women's health products.
• Digexin Patent-pending proprietary herbal extract combining tender okra pods and winter cherry (Ashwagandha) root to support digestive regularity and gut-brain axis communication through four mechanisms: epithelial lubrication, increased peristalsis, prebiotic effect, and adaptogenic cortisol/serotonin modulation. Sold to supplement brands for digestive health formulations; results clinically shown in 7 days.
• BluNADBooster Patent-pending, clinically studied plant-based NAD+ longevity ingredient combining pomegranate and marigold flower extracts to dual-pathway activate NAD+ biosynthesis (Salvage and Preiss-Handler pathways) and inhibit the CD38 enzyme. Marketed as a natural alternative to synthetic NAD+ precursors such as NR and NMN, for use in healthy aging and longevity supplement formulations.

Quantifiable outcome

• TamaFlex shows significant joint pain improvement in 5 days and improved physical function in 90-day studies with 89-150+ participants
• +3 more outcomes

Named customers13 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core.

• Twin Arbor LabscoreTechnology or Integration · 1 April 2026NXT-USA partnered with Twin Arbor Labs to establish the first independent testing method for Xeya Modern Shatavari extract. This partnership allows clients to independently confirm that every batch meets the same standards used in clinical research.
• Infinity Pharma BrazilcoreChannel Partner/ Reseller/ Distributor · 30 July 2024NXT-USA announced partnership with Infinity Pharma Brazil to launch Digexin in Brazil under the brand name Motility. This partnership expands global footprint and brings digestive wellness products to the Brazilian market.
• Shanghai Nutra (Shanghai Freemen)coreChannel Partner/ Reseller/ Distributor · 4 October 2022NXT-USA partnered with Shanghai Nutra to launch Digexin as a new digestive health ingredient at SupplySide West in October 2022. Shanghai Nutra serves as a distribution and co-marketing partner for the Chinese and Asian markets.
• Laila Nutra Private LimitedcoreStrategic or Co-development PartnerXeya trademark is owned by Laila Nutra Private Limited. NXT-USA has an exclusive or licensed relationship for the Xeya Modern Shatavari ingredient in global markets. Laila Nutra developed the proprietary extraction and standardization process delivering 15% shatavarins.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Sabinsa: Specializes in branded, patented, clinically validated botanical ingredients (e.g., curcumin C3 Complex, Boswellin) sold B2B to supplement manufacturers worldwide — directly comparable model to NXT-USA across turmeric/joint and women's health adjacencies.
• OmniActive Health Technologies: Supplies branded, science-backed nutraceutical ingredients (e.g., Lutemax, BioCurc) to brands globally — same B2B ingredient-supplier model, patent/trademark protected SKUs, and emphasis on peer-reviewed clinical evidence.
• Gencor: Global supplier of branded botanical extracts and ingredients (e.g., Libifem, Tesnor) targeting women's health, men's health, and general wellness — directly comparable ingredient portfolio and B2B go-to-market.
• PLT Health Solutions: B2B ingredient supplier focused on branded, clinically supported botanicals and naturals sold into supplement and functional food brands — comparable branded-ingredient distribution model.
• Nexira: Global supplier of natural botanical and nutritional ingredients with strong digestive-health and joint-health categories — directly comparable B2B ingredient model with overlap on gut-health adjacencies to Digexin.
• DolCas Biotech: Supplies branded, clinically researched botanical extracts (e.g., Curcugen, BosPure) to supplement manufacturers — same patented/standardized botanical B2B model with overlap on joint and inflammation categories.
• Verdure Sciences: Supplies branded, patented botanical extracts (e.g., Pomella, LongVida) to dietary supplement brands — comparable B2B ingredient model with emphasis on clinical substantiation and trademarked SKUs.
• Ingredients by Nature: Supplier of branded, research-backed botanical extracts (e.g., Curcumin C3, Prime Naturally) to supplement manufacturers — comparable B2B go-to-market and clinically validated positioning.
• Kuber Impex: India-based supplier of botanical and nutraceutical raw materials and proprietary extracts, including turmeric/curcumin derivatives — comparable upstream sourcing and B2B ingredient supplier model.
• Natural Remedies: India-headquartered manufacturer of clinically validated branded botanical extracts (e.g., BacoMind, Boswellia) supplied B2B to global supplement brands — directly comparable model on clinical validation, IP, and joint/women's health categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/nxt_usa
• LinkedInlinkedin.com/company/nxt-usa

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NXT-USA